Venture Map · Round

Aelix Therapeutics — Other · €1.858M

Announced 2021-09-15 · Barcelona · Biotech

Aelix Therapeutics, which develops a therapeutic HIV vaccine, received €1.858M through a CDTI Innvierte co-investment: €880K from CDTI and €978K between Caixa Innvierte Start and Ysios BioFund II Innvierte. No stage or lead was stated. The HQ city is not in the article and comes from background knowledge.

RoundOther Amount€1.858M LeadNot disclosed Date2021-09-15 CityBarcelona SectorBiotech

Source article ↗ · www.aelixtherapeutics.com ↗

The company

AELIX Therapeutics
aelixtherapeutics.com
Company Series A Barcelona

Investors 3

Caixa Innvierte Start (Criteria Caixa / Caixa Capital Risc)
www.caixacapitalrisc.es
InvestorSpain
CDTI Innvierte
www.cdti.es
InvestorSpain
Ysios BioFund II Innvierte (Ysios Capital)
www.ysioscapital.com
InvestorSpain

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close